Mothers’ Obesity May Pre-Program Children for Obesity, Metabolic Disease
Children may have a higher risk for fat accumulation and insulin resistance if their mothers were obese.
Children may have a higher risk for fat accumulation and insulin resistance if their mothers were obese.
Food insecurity has an impact on glycemic control and vegetable consumption in Latino patients with diabetes.
Gut-based medications like GLP-1 agonists may induce weight loss by reducing cravings and increasing satiety.
GLP-1 receptor agonist may be able to reduce glycemic variability rather than a prandial insulin.
Sitagliptin did not affect rates of cardiovascular complications or heart failure in high-risk patients with type 2 diabetes.
Lixisenatide has neutral effect on heart failure and other cardiovascular outcomes.
ITCA 650, which continuously delivers exenatide subcutaneously, yielded improvements in HbA1c and body weight in patients with type 2 diabetes.
Compared with insulin glargine, once-weekly dulaglutide led to superior reductions in HbA1c in patients with type 2 diabetes.
People with type 1 diabetes treated with basal insulin peglispro vs. insulin glargine had significantly lower HbA1c levels at 26 and 52 weeks.
Achieving greater HbA1c reductions with fixed-ratio combination insulin glargine/lixisenatide did not increase rates of hypoglycemia.